跳至主要内容
临床试验/NCT07675889
NCT07675889尚未招募不适用

Intraoperative Longitude-Latitude-Depth Three-Dimensional Localization Versus Preoperative CT-Guided Percutaneous Lung Puncture Localization for the Treatment of 0.8-2 cm Peripheral Pulmonary Nodules: A Multicenter, Randomized, Open-Label, Non-Inferiority Clinical Trial

Qilu Hospital of Shandong University4 个研究点 分布在 1 个国家目标入组 274 人开始时间: 2026年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
274
试验地点
4
主要终点
Localization Accuracy Rate

研究概览

简要总结

The goal of this clinical trial is to learn whether intraoperative longitude-latitude-depth three-dimensional localization (LLD localization) is non-inferior to preoperative CT-guided percutaneous lung puncture localization for identifying 0.8-2 cm peripheral pulmonary nodules in adults undergoing video-assisted thoracoscopic surgery (VATS)-assisted sublobar resection. It will also evaluate the safety and perioperative effectiveness of the two localization methods. The main questions it aims to answer are:

  1. Is the localization accuracy rate of LLD localization non-inferior to that of CT-guided percutaneous lung puncture localization?
  2. Does LLD localization improve perioperative outcomes, including localization time, postoperative recovery, pain, quality of life, and perioperative complication rates?

Researchers will compare LLD localization with CT-guided percutaneous lung puncture localization to determine whether LLD localization provides comparable localization accuracy while reducing procedure-related complications and improving perioperative outcomes.

Participants will:

  1. Be randomly assigned in a 1:1 ratio to either the LLD localization group or the CT-guided percutaneous lung puncture localization group.
  2. Undergo pulmonary nodule localization using the assigned localization method.
  3. Receive VATS-assisted sublobar resection following localization.
  4. Be assessed for localization accuracy, perioperative complications, localization time, postoperative chest drainage tube removal time, oxygenation index, postoperative hospital stay, pain scores, and quality-of-life outcomes.
  5. Complete follow-up assessments at 1, 3, and 6 months after surgery.

详细描述

Peripheral pulmonary nodules, particularly small subsolid nodules, are increasingly detected due to the widespread use of low-dose computed tomography (CT) screening. Accurate intraoperative identification of these nodules remains challenging during video-assisted thoracoscopic surgery because many lesions are difficult to visualize or palpate after lung collapse. Reliable localization is therefore essential to facilitate precise sublobar resection while preserving healthy lung tissue.

Preoperative CT-guided percutaneous localization techniques are widely used in clinical practice. However, these procedures require additional preoperative intervention and may be associated with complications such as pneumothorax, pulmonary hemorrhage, hemothorax, patient discomfort, and increased procedural complexity. Furthermore, successful localization depends on radiologic resources and coordination between multiple departments.

The longitude-latitude-depth (LLD) localization method is a novel intraoperative three-dimensional localization strategy developed to identify pulmonary nodules using anatomical reference lines and preoperative imaging measurements. The method utilizes the natural longitudinal and transverse landmarks of the collapsed lung together with the measured depth of the target lesion to estimate the spatial location of the nodule during surgery. Because localization is performed intraoperatively without transcutaneous puncture, the technique has the potential to reduce procedure-related trauma and simplify the clinical workflow.

Preliminary clinical experience suggests that the LLD localization method may provide accurate localization while avoiding several limitations associated with preoperative puncture-based approaches. However, high-quality prospective evidence comparing this technique with current standard localization methods remains limited.

This multicenter randomized controlled trial has been designed to provide rigorous clinical evidence regarding the performance of the LLD localization technique. The study will evaluate whether this novel approach can serve as an effective alternative to conventional CT-guided localization and support broader clinical application in the surgical management of peripheral pulmonary nodules.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinically diagnosed pulmonary nodule by non-contrast chest CT.
  • Age 18 to 80 years.
  • Expected survival time of at least 12 months.
  • Single peripheral pulmonary nodule with a diameter between 0.8 cm and 2 cm.
  • Chest CT characteristics meeting both of the following criteria:
  • Solid component proportion ≤50%.
  • Located subpleurally or in the outer one-third of the lung parenchyma.
  • Willing to undergo VATS-assisted sublobar resection.
  • No contraindications to pulmonary localization procedures or surgery.
  • Able to understand the study and willing to sign written informed consent.

排除标准

  • Use of other localization methods or other surgical procedures.
  • Concurrent participation in another clinical study.
  • Pregnancy.
  • Unwillingness or inability to cooperate with participation in this study for any reason.

结局指标

主要结局

Localization Accuracy Rate

时间窗: Intraoperatively on day 0.

Localization accuracy rate is defined as the percentage of participants with successful localization, calculated as (number of successfully localized participants / total number of participants) × 100%. Localization is deemed successful if the actual distance between the localization point and the true nodule center, or its surface projection, is 1 cm or less. A distance exceeding 1 cm is classified as localization failure. After removal of the pulmonary nodule, measure the distance from the nodule center to the marked localization point with a ruler and record the value.

次要结局

  • Perioperative Complication Rate(From the initiation of the localization procedure through hospital discharge, up to 14 days post-surgery.)
  • Postoperative Pain Score (VAS)(Postoperative day 1, day 2, day 3, and day 7.)
  • Localization Time(During the localization procedure on day 0 (from the start of localization to its confirmed completion, approximately 5-20 minutes).)
  • Postoperative Chest Drainage Tube Removal Time(From the completion of surgery to chest drainage tube removal, assessed up to 14 days post-surgery.)
  • Oxygenation Index(Postoperative day 1 and day 2.)
  • Postoperative Length of Hospital Stay(From the completion of surgery to hospital discharge, assessed up to 30 days.)
  • Quality of Life Score (EORTC QLQ-C30)(Postoperative month 1, month 3, and month 6.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Zhenguo Sun

Associate Professor

Qilu Hospital of Shandong University

研究点 (4)

Loading locations...

相似试验